Efficacy and Safety of Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiovascular Autonomic Neuropathy: Systematic Review and Meta-Analysis

BACKGROUND: Aldose reductase inhibitors (ARIs) can block the metabolism of the polyol pathway, and have been used to slow or reverse the progression of diabetic cardiovascular autonomic neuropathy (DCAN). The purpose of this study was to review the effectiveness and safety of ARIs in the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xin, Li, Shengbing, Yang, Gangyi, Liu, Hua, Boden, Guenther, Li, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922720/
https://www.ncbi.nlm.nih.gov/pubmed/24533052
http://dx.doi.org/10.1371/journal.pone.0087096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922720/
https://www.ncbi.nlm.nih.gov/pubmed/24533052
http://dx.doi.org/10.1371/journal.pone.0087096

Ejemplares similares